CSIMarket



Abbott Laboratories  (ABT)
Other Ticker:  
 
 

ABT's Free Cash Flow Growth by Quarter and Year

Abbott Laboratories's Free Cash Flow results by quarter and year




ABT Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 3,067.00 3,798.00 2,416.00
III Quarter September - 2,701.00 2,066.00 1,948.00
II Quarter June - 2,128.00 1,322.00 1,060.00
I Quarter March 2,065.00 2,637.00 715.00 712.00
FY   2,065.00 10,533.00 7,901.00 6,136.00



ABT Free Cash Flow first quarter 2022 Y/Y Growth Comment
Abbott Laboratories reported decline in Free Cash Flow in the first quarter 2022 by -21.69% to $ 2,065.00 millions, from the same quarter in 2021.
The contraction in the first quarter 2022 Abbott Laboratories's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow growth of 1.9%.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Free Cash Flow growth. While Abbott Laboratories' s Free Cash Flow fall of -21.69% ranks overall at the positon no. 476 in the first quarter 2022.




ABT Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -19.25 % 57.2 % 36.88 %
III Quarter September - 30.74 % 6.06 % -10.77 %
II Quarter June - 60.97 % 24.72 % -14.79 %
I Quarter March -21.69 % 268.81 % 0.42 % -35.74 %
FY   - 33.31 % 28.76 % -2.6 %

Financial Statements
Abbott Laboratories's first quarter 2022 Free Cash Flow $ 2,065.00 millions ABT's Income Statement
Abbott Laboratories's first quarter 2021 Free Cash Flow $ 2,637.00 millions Quarterly ABT's Income Statement
New: More ABT's historic Free Cash Flow Growth >>


ABT Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 13.55 % 83.83 % 24.02 %
III Quarter September - 26.93 % 56.28 % 83.77 %
II Quarter June - -19.3 % 84.9 % 48.88 %
I Quarter March -32.67 % -30.57 % -70.41 % -59.66 %
FY (Year on Year)   - 33.31 % 28.76 % -2.6 %




Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #33
Overall #476

Free Cash Flow Y/Y Growth Statistics
High Average Low
29.62 % 1.9 % -58.14 %
(Sep. 30, 2014)   (Sep. 30, 2013)
Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #33
Overall #476
Free Cash Flow Y/Y Growth Statistics
High Average Low
29.62 % 1.9 % -58.14 %
(Sep. 30, 2014)   (Sep. 30, 2013)

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Abbott Laboratories's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
802.06 % 53.53 % -100 %
(June 30. 2005)  


ABT's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2022 Abbott Laboratories realized fall in Free Cash Flow sequentially by -32.67% to $ 2,065.00 millions, from $ 3,067.00 millions declared in the previous reporting period.

If you analyse recent shortcoming in the quarter, you should take into consideration, that commonly I. Quarter Free Cash Flow occur softer relative to the quarter before

Within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Abbott Laboratories's Free Cash Flow growth quarter on quarter, overall rank is 312.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #22
Overall #312
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #22
Overall #312
Free Cash Flow Q/Q Growth Statistics
High Average Low
802.06 % 53.53 % -100 %
(June 30. 2005)  


ABT's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2022 Abbott Laboratories disclosed fall in Free Cash Flow from the previous quarter by -32.67% to $ 2,065.00 millions, from $ 3,067.00 millions released in the previous reporting period.

When you analyse present slump in the quarter, you suppose to assume, that usually I. Quarter 2022 results emerge sluggish then in the quarter before

Within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Abbott Laboratories's Free Cash Flow growth quarter on quarter, overall rank is 312.


Abbott Laboratories's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Free Cash Flow 12 Months Ending $ 11,770.00 $ 12,418.00 $ 13,214.00 $ 12,614.00 $ 12,037.00
Y / Y Free Cash Flow Growth (TTM) -2.22 % 23.22 % 56.36 % 53.12 % 54.28 %
Year on Year Free Cash Flow Growth Overall Ranking # 406 # 285 # 344 # 400 # 377
Seqeuential Free Cash Flow Change (TTM) -5.22 % -6.02 % 4.76 % 4.79 % 19.44 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 476 # 529 # 743 # 1274 # 667




Cumulative Free Cash Flow growth Comment
For the 12 months ended Mar 31 2022 Abbott Laboratories reported a decrease in Free Cash Flow by -2.22% year on year, to $11,770 millions, compare to the 23.22% growth at Dec 31 2021.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 285 to 406.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
29.62 %
1.9 %
-58.14 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 28
Overall # 406

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
58.76 %
13.1 %
-65.04 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 33
S&P 500 # 476
Cumulative Free Cash Flow growth Comment
For the 12 months ended Mar 31 2022 Abbott Laboratories reported a decrease in Free Cash Flow by -2.22% year on year, to $11,770 millions, compare to the 23.22% growth at Dec 31 2021.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 285 to 406.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
29.62 %
1.9 %
-58.14 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 28
Overall # 406

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
58.76 %
13.1 %
-65.04 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 33
S&P 500 # 476




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ABT's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ABT's Competitors
Free Cash Flow Growth for Abbott Laboratories's Suppliers
Free Cash Flow Growth for ABT's Customers

You may also want to know
ABT's Annual Growth Rates ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons



Companies with similar Free Cash Flow decrease for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2022
Bristol myers Squibb Company-0.31%$ -0.314 millions
Bio techne Corp-2.32%$ -2.321 millions
Edwards Lifesciences Corporation-2.40%$ -2.396 millions
Chemed Corporation-5.27%$ -5.275 millions
Moderna Inc -7.00%$ -7.001 millions
Idexx Laboratories Inc-7.81%$ -7.809 millions
Abcellera Biologics Inc -8.51%$ -8.513 millions
Utah Medical Products Inc-8.80%$ -8.802 millions
Amedisys Inc-9.96%$ -9.964 millions
Sotera Health Company-11.03%$ -11.026 millions
Royalty Pharma Plc-12.51%$ -12.513 millions
Ironwood Pharmaceuticals inc -12.99%$ -12.986 millions
Quidel Corporation-14.43%$ -14.431 millions
Endo International Plc-17.44%$ -17.438 millions
Amneal Pharmaceuticals Inc -18.76%$ -18.757 millions
Fulgent Genetics Inc -19.20%$ -19.199 millions
Medpace Holdings Inc -19.30%$ -19.301 millions
Bruker Corporation-20.61%$ -20.612 millions
Abbott Laboratories-21.69%$ -21.691 millions
Lemaitre Vascular Inc-22.44%$ -22.440 millions
Zoetis Inc -22.75%$ -22.750 millions
Axon Enterprise inc -27.86%$ -27.856 millions
Gilead Sciences Inc -29.50%$ -29.502 millions
Hca Healthcare Inc -32.34%$ -32.344 millions
U S Physical Therapy Inc-34.09%$ -34.090 millions
Quest Diagnostics Inc-34.34%$ -34.337 millions
Integra Lifesciences Holdings Corp-35.81%$ -35.809 millions
Co diagnostics Inc -36.38%$ -36.383 millions
Rackspace Technology Inc -37.50%$ -37.500 millions
Charles River Laboratories International inc -39.71%$ -39.711 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EDTK's Profile

Stock Price

EDTK's Financials

Business Description

Fundamentals

Charts & Quotes

EDTK's News

Suppliers

EDTK's Competitors

Customers & Markets

Economic Indicators

EDTK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071